// App-Quantinova.ai

31 : Anti-PD-1 antibody cetrelimab (JNJ-63723283) in patients with advanced cancers: Updated phase I/II study results.

Researchers

Presenter

  • Piotr Rutkowski

Principal Investigators

  • Victor Moreno

  • Jose Manuel Trigo Perez

  • Aitana Calvo

  • Dariusz Kowalski

  • Diego Cortinovis

  • James J. Lee

  • George Manikhas

  • Elizabeth Ruth Plummer

  • Michele Maio

  • Paolo Antonio Ascierto

  • Vladimir Ivanovich Vladimirov

  • Dana Gaffney

  • Lilian Y. Li

  • Kyounghwa Bae

  • James G. Greger

  • Chu Ri Shin

  • Hong Xie

  • Emiliano Calvo

Medical Centers

  • Centrum Onkologii-Instytut im. M. Sklodowskiej Curie, Warszawa, Poland

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • START MADRID-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain

  • IBIMA-Hospital Regional Universitario y Virgen de la Victoria, Malaga, Spain

  • Hospital Universitario Quiron Madrid, Madrid, Spain

  • San Gerardo Hospital, Monza, Italy

  • University of Pittsburgh, Pittsburgh, PA

  • St. Petersburg City Oncological Dispensary, St. Petersburg, Russia

  • Sir Bobby Robson Unit, Northern Centre for Cancer Care, Newcastle, United Kingdom

  • Azienda Ospedaliera Universitaria Senese, Siena, Italy

  • INT Fondazione G. Pascale, Naples, Italy

  • Pyatigorsk Oncology Dispensary, Pyatigorsk, Russian Federation

  • Janssen Research and Development, LLC, Spring House, PA

  • START Department, Centro Integral Oncologico Clara Campal, Madrid, Spain

Locations

  • Poland

  • Spain

  • Italy

  • United States

  • Russia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Colorectal Cancer

  • Esophageal Cancer

  • Unspecified Cancer

  • Lung Cancer

  • Melanoma

  • Solid malignancies

  • Small cell lung cancer

Biomarkers

  • Microsatellite instability-high

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • I/II

Study Id's

  • NCT02908906

Sponsors

  • N/A

Result

  • N/A